Clinical Trials Browser

Phase 1 × Solid Tumor, Adult × Immune Checkpoint Inhibitors × Clear all

NCT06026254 2024-11-18

A Rollover Study for Subjects Who Completed Participation in IMSA101-101 Trial

Phase 1 Active not recruiting

Other solid neoplasm

Solid Tumor, Adult